Your account is not claimed yet. You can sign up with ORCID to claim your account.

Sarai Palanca Suela (S Palanca Suela, Sarai Palanca)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Venues

International journal of molecular sciences

Cancers

JCO precision oncology

Diagnostics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

José Vicente Gil, Esperanza Such, Claudia Sargas, Javier Simarro, Alberto Miralles, Gema Pérez, Inmaculada de Juan, Sarai Palanca Suela, Gayane Avetisyan, Marta Santiago, Carolina Fuentes, José María Fernández, Ana Isabel Vicente, Samuel Romero, Marta Llop, Eva Barragán
Design and Validation of a Custom Next-Generation Sequencing Panel in Pediatric Acute Lymphoblastic Leukemia. International journal of molecular sciences 24 (5) (2023)
Javier Simarro, Gema Pérez-Simó, Nuria Mancheño, Emilio Ansotegui, Carlos Francisco Muñoz-Núñez, José Gómez-Codina, Oscar Juan-Vidal, Sarai Palanca Suela
Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare Hospital. Cancers 15 (6) (2023)
José Vicente Gil, Esperanza Such, Claudia Sargas, Javier Simarro, Alberto Miralles, Gema Pérez, Inmaculada de Juan, Sarai Palanca Suela, Gayane Avetisyan, Marta Santiago, Carolina Fuentes, José María Fernández, Ana Isabel Vicente, Samuel Romero, Marta Llop, Eva Barragán
Design and Validation of a Custom Next-Generation Sequencing Panel in Pediatric Acute Lymphoblastic Leukemia. International journal of molecular sciences 24 (5) (2023)
Edurne Arriola, Reyes Bernabé, Rosario García Campelo, Michele Biscuola, Ana Belén Enguita, Fernando López-Ríos, Rafael Martínez, Laura Mezquita, Sarai Palanca Suela, María Jesús Pareja, Jon Zugazagoitia, Natalia Arrabal, J Francisco García, David Carcedo, Enrique de Álava
Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non-Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers. JCO precision oncology 7 (2023)
José Vicente Gil, Esperanza Such, Claudia Sargas, Javier Simarro, Alberto Miralles, Gema Pérez, Inmaculada de Juan, Sarai Palanca Suela, Gayane Avetisyan, Marta Santiago, Carolina Fuentes, José María Fernández, Ana Isabel Vicente, Samuel Romero, Marta Llop, Eva Barragán
Design and Validation of a Custom Next-Generation Sequencing Panel in Pediatric Acute Lymphoblastic Leukemia. International journal of molecular sciences 24 (5) (2023)
Javier Simarro, Gema Pérez-Simó, Nuria Mancheño, Emilio Ansotegui, Carlos Francisco Muñoz-Núñez, José Gómez-Codina, Oscar Juan-Vidal, Sarai Palanca Suela
Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare Hospital. Cancers 15 (6) (2023)
Edurne Arriola, Reyes Bernabé, Rosario García Campelo, Michele Biscuola, Ana Belén Enguita, Fernando López-Ríos, Rafael Martínez, Laura Mezquita, Sarai Palanca Suela, María Jesús Pareja, Jon Zugazagoitia, Natalia Arrabal, J Francisco García, David Carcedo, Enrique de Álava
Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non-Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers. JCO precision oncology 7 (2023)
Javier Simarro, Gema Pérez-Simó, Nuria Mancheño, Emilio Ansotegui, Carlos Francisco Muñoz-Núñez, José Gómez-Codina, Oscar Juan-Vidal, Sarai Palanca Suela
Technical Validation and Clinical Implications of Ultrasensitive PCR Approaches for EGFR -Thr790Met Mutation Detection in Pretreatment FFPE Samples and in Liquid Biopsies from Non-Small Cell Lung Cancer Patients. International journal of molecular sciences 23 (15) (2022)
Javier Simarro, Gema Pérez-Simó, Nuria Mancheño, Carlos Francisco Muñoz-Núñez, Enrique Cases, Oscar Juan-Vidal, Sarai Palanca Suela
Utility of Next-Generation Sequencing in the Reconstruction of Clonal Architecture in a Patient with an EGFR Mutated Advanced Non-Small Cell Lung Cancer: A Case Report. Diagnostics (Basel, Switzerland) 12 (5) (2022)
José Miguel Pardo-Sánchez, Nuria Mancheño, José Cerón, Carlos Jordá, Emilio Ansotegui, Oscar Juan-Vidal, Sarai Palanca Suela, Antonio Cremades, Carolina Gandía, Rosa Farràs
Correction: Pardo-Sánchez et al. Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation. Cancers 2021, 13, 2980. Cancers 13 (19) (2021)
Estefanía Tarazón, Blanca de Unamuno Bustos, Rosa Murria Estal, Gema Pérez Simó, Antonio Sahuquillo-Torralba, Javier Simarro, Sarai Palanca Suela, Rafael Botella Estrada
MiR-138-5p Suppresses Cell Growth and Migration in Melanoma by Targeting Telomerase Reverse Transcriptase. Genes 12 (12) (2021)
B de Unamuno Bustos, R Murria Estal, G Pérez Simó, J Simarro Farinos, C Pujol Marco, M Navarro Mira, V Alegre de Miquel, R Ballester Sánchez, V Sabater Marco, M Llavador Ros, Sarai Palanca Suela, R Botella Estrada
Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma. The British journal of dermatology 179 (2) (2018)

Sarai Palanca Suela.css-eqlu8i{font-size:small;padding-left:4px;} (S Palanca Suela, Sarai Palanca)

Publication Activity (10 Years)

Top Topics

Top Venues

Sarai Palanca Suela (S Palanca Suela, Sarai Palanca)